ArticleMedical molecular morphology2021

High T-cell infiltration in tumor tissue and younger age predict the response to pembrolizumab in recurrent urothelial cancer.

Toshiki Anami et al.PubMed ↗Publisher ↗

No numbers read from the abstract.